LFSTNasdaqServices-Health ServicesFiscal year ends December 31
LifeStance Health Group, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$11.77+0.03 (+0.26%)
Close on Oct 19, 2026
- Market cap
- $4.56B
- P/E (TTM)
- 90.5
- Dividend yield
- –
Share price
+$6.73 (+133.5%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
LifeStance Health Group, Inc. grew revenue 20.4% to $1.58B over the twelve months to Jun 30, 2026. Free cash flow was $173.91M, up 44.8% from a year earlier.
Revenue
$1.58B
+20.4% vs. a year earlier
Operating income
$78.43M
TTM Q2 2026
Free cash flow
$173.91M
+44.8% vs. a year earlier
EPS, diluted
$0.13
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $4.56B
- P/E ratio
- 90.5
- Price to sales
- 2.88
- Price to book
- 3.09
- Dividend yield
- –
- Free cash flow yield
- 3.81%
Fundamentals
- Revenue
- $1.58B
- Net income
- $50.60M
- EPS, diluted
- $0.13
- Free cash flow
- $173.91M
- Book value per share
- $3.81
- Diluted shares
- 387M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
$1.58B+20.4% YoY
Operating income
$78.43M
Net income
$50.60M
EPS, diluted
$0.13
Free cash flow
$173.91M+44.8% YoY
Reported periodTrailing twelve months